Abstract
Frail older people are still under-represented in clinical trials. The evidence-base for clinical decisionmaking in this age group is poor even though older patients are the core business of health services. We examine possible causes for the exclusion of older people from clinical trials and propose possible solutions for this unjust and inequitable situation. Some progress has been made but more needs done to ensure equality and uniformly high standards of health care for older people.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Keime-Guibert F, Abellan G, Nourhashemi F, Tsouderos Y, Merdes A, Vellas B. Rational for a minimum data set for clinical trials with geriatric patients. J Nutr Health Aging 2007;11;3: 273–277
Scottish Executive. Adding Life to Years. Report of the expert group on healthcare of older people. Edinburgh: Scottish Executive, 2002
Key Health Statistics from General Practice 1998. Analyses of morbidity and treatment data, including time trends, England and Wales. Series MB6 No2. Office for National Statistics
Cancer Statistics registrations. Registrations of cancer diagnosed in 2004, England. Series MBI No35, Office for National Statistics
Cowie MR, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, Suresh V and Sutton GC. Incidence and aetiology of heart failure. A population-based study. European Heart Journal 1999;20: 421–428
Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347;18: 1397–1402
Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and Occurrence of Total (First-Ever and Recurrent) Stroke. Stroke 1999;30: 2523–2528
MeReC Bulletin, National Prescribing Centre NHS, Vol 11, No10 April 2000
Ritz P, Vellas B. Pharmacokinetics and drug toxicity in elderly patients: a case for geriatric core data in clinical trials. J Nutr Health Aging. 2007;11;3: 261–264
CAST (Chinese Acute Stroke Trial) Collaborative Group: randomised placebocontrolled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet 1997;349: 1641–1649
Davis BR, Piller LB, Cutler JA et al. for the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group. Role of Diuretics in the Prevention of Heart Failure. Circulation 2006;113: 2201–2210
The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study), Lancet 2003; 362: 782–788
The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in highrisk patients, N Engl J Med 2000;342;3: 145–153
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J for the Randomised Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341(10): 709–717
MRC/BHF Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360: 7–22
Townsley CA, Selby R, Siu LL. Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials. J Clin Oncol 2005;23: 3112–24
McMurdo MET, Witham MD, Gillespie ND. Including older people in clinical research. BMJ 2005;331: 1036–1037
Witham MD, Gillespie ND, Struthers AD. Tolerability of spironolactone in patients with chronic heart failure — a cautionary message. Br J Clin Pharmacol 2004; 58: 5, 554–557
Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of Hyperkalaemia after Publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351: 543–551
Peterson ED, Lytle BL, Alexander KP, Coombs LP. Willingness of Under-Represented Groups to Participate in Clinical Trials. J Am Coll Cardiol 2005;39: 435A
Williams B, Irvine L, McGinnis AR, McMurdo MET, Crombie IK. When “no” might not quite mean “no”; the importance of informed and meaningful non-consent. Results from a survey of individuals refusing participation in a health-related research project. BMC Health Services Research 2007;7: 59
National Institute of Health Policy and Guidelines on the inclusion of Women and Minorities as Subjects in Clinical Research — Amended October 2001. Accessed October 2007 http://grants.nih.gov/grants/funding/women_min/women_min.htm
Marshall E. From Dearth to Deluge. Science 2005;308;5728: 1570–1572
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Habicht, D.W., Witham, M.D. & Mcmurdo, M.E.T. The under-representation of older people in clinical trials: Barriers and potential solutions. J Nutr Health Aging 12, 194–196 (2008). https://doi.org/10.1007/BF02982619
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02982619